Psychopharmacology is the learning of the effects of medication on the psyche (psychology), observing changed behaviors and how molecular events are manifest in a measurable behavioral form. The treatments may cause side effects such as induction of the metabolic syndrome, type II diabetes related to the medications prescribed for management of psychiatric and behavioural disorders and disturbances. The effectiveness of the drugs can be increased by prescriber’s knowledge over emotional and interpersonal issues of the patient i.e. psychology of psychopharmacology. Schizophrenia is such a disorder which affects the thinking and acting ability of a person caused by viral infection, genetically or by immune disorder.

The global mental health pharmaceutical market can be estimated at $80 billion in 2010. This market is expected to increase at a 1.9% compound annual growth rate (CAGR) over the forecast period to reach a value of $88 billion in 2015.

Neurogenesis and repair deal with other aspects on the indications for medications prescribed to address psychiatric and behavioral problems, that are associated with, including antipsychotic, anxiolytic and anticonvulsant medications, acquired brain injury and psychopharmacology drugs and their interaction with neurotransmitters also include mood stabilizers and treatments prescribed for disorders of attention.

  • Preclinical psychopharmacology
  • Clinical and translational psychopharmacology
  • Psychopharmacology drugs and their interaction with neurotransmitters
  • Dose response relation in psychiatric medications
  • Effect of androgenic anabolic steroids on psychosis
  • Schizophrenia and its dependence on brain chemistry and structure
  • Psychology of psychopharmacology

Related Conference of Psychopharmacology

Oct 31- Nov 02, 2016

5th International Conference on Forensic Research & Technology

San Francisco, California, USA
Nov 07-09, 2016

4th International Pharma & Clinical Pharmacy Congress

Las Vegas, Nevada, USA
Nov 07-09, 2016

4th International Pharma & Clinical Pharmacy Congress

Las Vegas, Nevada, USA
April 17-18, 2017

8th Global Pharmacovigilance & Drug Safety Summit

Bali, Indonesia
May 08-10, 2017

10th Asia-Pacific Pharma Congress

May 15-17, 2017

7th European Biosimilars Congress

Munich, Germany
May 22-23, 2017

World Congress on Biotherapeutics

Mexico city, Mexico
July 10-12, 2017

9th Annual European Pharma Congress

Madrid, Spain
July 17-19, 2017

International Conference on Pigmentary Disorders

Melbourne, Australia
July 17-19, 2017

9th World Congress on BA/BE Studies and Biowaivers

Melbourne, Australia
July 24-26, 2017

8th World Congress on Pharmacology and Toxicology

Melbourne, Australia
July 31-Aug 02, 2017

7th Global Experts Meeting on Neuropharmacology

Milan, Italy
August 03-04, 2017

4th International Conference and Exhibition on Pain Medicine

San Francisco, USA
August 07-09, 2017

8th World Congress on Pharmacology

Paris, France
August 17-18, 2017

11th Annual Global Pharma Summit

San Francisco, USA
April 27-28, 2017

5th International Pharmacy Conference

Las Vegas, USA
Aug 21-22, 2017

Global Summit on Emerging Orphan Drugs and  Drug Abuse

San Francisco, USA
September 14-16, 2017

Immunology World

Amsterdam, Netherlands
September 18-19, 2017

International Conference on Next Generation Nanotechnology

Jackson Ville, USA
Sep 25-27, 2017

10th Pharmacovigilance Congress

Jackson Ville, USA
Sep 25-27, 2017

8th Annual Pharmaceutical Analysis Congress

Vienna, Austria
Sep 25-27, 2017

12th Annual Pharma Middle East Congress

Dubai, UAE
October 16-18, 2017

World Congress on Natural Products Chemistry and Research

Budapest, Hungary
October 19-21, 2017

9th Annual Congress on Drug Formulation & Drug Design

Seoul, South Korea
October 23-25, 2017

International Conference on Biotech Pharmaceuticals

Paris, France
September 11-13, 2017

4th International Conference on Clinical Trials

San Antonio, USA

Psychopharmacology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in